The outcome of lymphoma has definitely improved over the last few decades which is mainly due to the introduction and development of novel and effective therapeutic approaches. Nevertheless, a small though notable group of patients may display a poor response to treatments, with a true refractoriness or a transient response followed by early relapse. The present review addresses the issue of refractory disease among patients with lymphoma, focusing on the overall incidence and the main clinical aspects associated with refractoriness.
The issue of refractory disease in follicular and other lymphoma subtypes / M. Ruella, A. Gueli, A. Risso, I. Ricca, D. Gottardi, A. de Crescenzo, R. Passera, M. Ladeto, C. Tarella. - In: REVISTA BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. - ISSN 1516-8484. - 31:suppl. 2(2009), pp. 15-18.
The issue of refractory disease in follicular and other lymphoma subtypes
C. Tarella
2009
Abstract
The outcome of lymphoma has definitely improved over the last few decades which is mainly due to the introduction and development of novel and effective therapeutic approaches. Nevertheless, a small though notable group of patients may display a poor response to treatments, with a true refractoriness or a transient response followed by early relapse. The present review addresses the issue of refractory disease among patients with lymphoma, focusing on the overall incidence and the main clinical aspects associated with refractoriness.
| File | Dimensione | Formato | |
|---|---|---|---|
|
a05v31s2.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
225.08 kB
Formato
Adobe PDF
|
225.08 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
